Pancreatic cancer patients with germline BRCA mutations can benefit from olaparib treatment
@article{TCR38108,
author = {Shibani Mukherjee and Aroumougame Asaithamby},
title = {Pancreatic cancer patients with germline BRCA mutations can benefit from olaparib treatment},
journal = {Translational Cancer Research},
volume = {9},
number = {4},
year = {2020},
keywords = {},
abstract = {},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/38108}
}